AHRR Antibodies

Santa Cruz Biotechnology delivers a wide array of AHRR monoclonal antibodies for investigating aryl hydrocarbon receptor repressor (AHRR) protein. AHRR Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AHRR plays a central role in regulating the activity of the aryl hydrocarbon receptor (AHR), which mediates the effects of environmental toxins and endogenous ligands. Through modulation of AHR signaling, AHRR maintains cellular homeostasis and provides protection against toxic insults. Research has shown that AHRR expression influences various biological processes and may impact multiple disease states. Scientists can utilize AHRR monoclonal antibodies to examine protein localization, expression patterns, and molecular interactions. Advanced research techniques supported by AHRR monoclonal antibodies enable detailed analysis of signaling pathways and regulatory mechanisms. Understanding AHRR function continues to reveal new insights into cellular responses and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for AHRR support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies.